» Articles » PMID: 21559944

A Complete Deficiency of Hyaluronoglucosaminidase 1 (HYAL1) Presenting As Familial Juvenile Idiopathic Arthritis

Overview
Publisher Wiley
Date 2011 May 12
PMID 21559944
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

We describe a single consanguineous family with three affected children exhibiting knee and/or hip pain associated with swelling. Detailed clinical evaluation demonstrated diffuse joint involvement with an unusual proliferative synovitis on MRI. Synovial biopsies were notable for an infiltration of macrophages with abundant cytoplasm filled with faintly basophilic vacuoles. We used homozygosity mapping with a panel of 262,000 single nucleotide polymorphism markers to identify a homozygous stretch of 40.52 Mb on chromosome 3p22.3 - 3p13 that segregated with the arthropathy in the family. Of the 378 genes in the interval, the three hyaluronoglucosaminidase genes were considered good candidates based on the phenotype. Dideoxy sequencing identified a homozygous deletion in HYAL1, c.104delT, resulting in a premature termination codon, p.Val35AlafsX25, found in all three affected children. Enzymatic analysis confirmed total HYAL1 deficiency in the three affected children. This confirms the diagnosis of Mucopolysaccharidosis IX (MPS IX) which has only been described in a single patient to date. In contrast to the previously described MPS IX patient, our three patients display a phenotype limited to the joints, suggesting that this is the primary manifestation of HYAL1 deficiency.

Citing Articles

Assessment of genes involved in lysosomal diseases using the ClinGen clinical validity framework.

Groopman E, Mohan S, Waddell A, Wilke M, Fernandez R, Weaver M Mol Genet Metab. 2024; 143(3):108593.

PMID: 39426251 PMC: 11560485. DOI: 10.1016/j.ymgme.2024.108593.


Mucopolysaccharidosis-Plus Syndrome: Is This a Type of Mucopolysaccharidosis or a Separate Kind of Metabolic Disease?.

Cyske Z, Gaffke L, Pierzynowska K, Wegrzyn G Int J Mol Sci. 2024; 25(17).

PMID: 39273517 PMC: 11395409. DOI: 10.3390/ijms25179570.


Genetic Deficiencies of Hyaluronan Degradation.

Fink S, Triggs-Raine B Cells. 2024; 13(14.

PMID: 39056785 PMC: 11275217. DOI: 10.3390/cells13141203.


Molecular Mechanisms in Pathophysiology of Mucopolysaccharidosis and Prospects for Innovative Therapy.

Ago Y, Rintz E, Musini K, Ma Z, Tomatsu S Int J Mol Sci. 2024; 25(2).

PMID: 38256186 PMC: 10816168. DOI: 10.3390/ijms25021113.


Role of the Lactide:Glycolide Ratio in PLGA Nanoparticle Stability and Release under Lysosomal Conditions for Enzyme Replacement Therapy of Lysosomal Storage Disorders.

Del Moral M, Loeck M, Muntimadugu E, Vives G, Pham V, Pfeifer P J Funct Biomater. 2023; 14(9).

PMID: 37754854 PMC: 10531859. DOI: 10.3390/jfb14090440.


References
1.
Savolainen A, Saila H, Kotaniemi K, Kaipianen-Seppanen O, Leirisalo-Repo M, Aho K . Magnitude of the genetic component in juvenile idiopathic arthritis. Ann Rheum Dis. 2001; 59(12):1001. PMC: 1753050. DOI: 10.1136/ard.59.12.1001. View

2.
Seelow D, Schuelke M, Hildebrandt F, Nurnberg P . HomozygosityMapper--an interactive approach to homozygosity mapping. Nucleic Acids Res. 2009; 37(Web Server issue):W593-9. PMC: 2703915. DOI: 10.1093/nar/gkp369. View

3.
Prahalad S, Zeft A, Pimentel R, Clifford B, McNally B, Mineau G . Quantification of the familial contribution to juvenile idiopathic arthritis. Arthritis Rheum. 2010; 62(8):2525-9. PMC: 2921017. DOI: 10.1002/art.27516. View

4.
Prahalad S . Genetics of juvenile idiopathic arthritis: an update. Curr Opin Rheumatol. 2004; 16(5):588-94. DOI: 10.1097/01.bor.0000134407.48586.b0. View

5.
Schwarz J, Rodelsperger C, Schuelke M, Seelow D . MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010; 7(8):575-6. DOI: 10.1038/nmeth0810-575. View